Controlled Substances Act Clarification in Sciences Act of 2026
Rep. Cohen Introduces Bill to Modernize How the Government Classifies Controlled Substances
This bill is currently in the early stages of the legislative process. It has been sent to two House committees for review and is not yet scheduled for a vote. The bill is considered active as it waits for further action from these committees.
Legislative Progress
This bill faces a difficult path because it changes long-standing drug laws and shifts power away from law enforcement, which often causes disagreement in Congress.
Key Points
Impact Analysis
Personal Impact
Life & Work
If this bill leads to the rescheduling or descheduling of certain substances, it could reduce future criminal exposure for people who use those substances. While it would not retroactively clear anyone's record, a more science-based scheduling framework could mean fewer people face criminal charges for substances that medical experts consider relatively low-risk.
Disabilities
Activities
Milestones
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
News
No related news coverage found for this legislation yet.
Source Information
Document Type
Congressional Bill
Official Title
Controlled Substances Act Clarification in Sciences Act of 2026
Data Sources
Sponsor
Analysis generated by AI. Always verify with official sources.